News

A dozen Canadian groups are leading exhibition at this year's Venice Biennale, which opened this month. Here's what they have ...
New York's Chelsea Gallery District becomes the launch pad for a dystopian spectacle masquerading as a campaign rollout. "Opposing Visions: The Trump Era in Art" unveils its provocative centerpiece: ...
Carolina Handling Partners With Spire At Talladega Race. Fair At Heritage Park In Simpsonville showcases new foods, rides and shows. In The Know 5-18 ...
Longtime Omaha television reporter John Chapman is honored with his Face on the Barroom Floor at the Omaha Press Club.
In a look ahead at a week of Cambridge and Somerville events, Inman Eats & Crafts is back, there's a Harvard Square Block ...
Bringing together ideas from both biotechnology ... that this exhibition shines a light on the challenges and opportunities ahead. At Tate & Lyle, our passion for science and tech has driven our ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...
Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing company running without interruption and uphold its privacy-protection ...